A Study of ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)
Clinical trial NCT02634346 · COMPLETED
Trial details
- NCT number
- NCT02634346
- Sponsor
- Alkermes, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-05-25
- Enrollment
- 403
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.